BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 9103465)

  • 1. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes.
    Ahlers JD; Dunlop N; Alling DW; Nara PL; Berzofsky JA
    J Immunol; 1997 Apr; 158(8):3947-58. PubMed ID: 9103465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine.
    Hartoonian C; Ebtekar M; Soleimanjahi H; Karami A; Mahdavi M; Rastgoo N; Azadmanesh K
    Cytokine; 2009 Apr; 46(1):43-50. PubMed ID: 19278866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Tokushige K; Wands JR
    J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.
    Weiss WR; Ishii KJ; Hedstrom RC; Sedegah M; Ichino M; Barnhart K; Klinman DM; Hoffman SL
    J Immunol; 1998 Sep; 161(5):2325-32. PubMed ID: 9725227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cytokine synergy essential for vaccine protection against viral challenge.
    Ahlers JD; Belyakov IM; Matsui S; Berzofsky JA
    Int Immunol; 2001 Jul; 13(7):897-908. PubMed ID: 11431420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
    Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen.
    Kim JJ; Ayyavoo V; Bagarazzi ML; Chattergoon MA; Dang K; Wang B; Boyer JD; Weiner DB
    J Immunol; 1997 Jan; 158(2):816-26. PubMed ID: 8992999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
    Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K
    J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
    J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice.
    Geissler M; Schirmbeck R; Reimann J; Blum HE; Wands JR
    Hepatology; 1998 Jul; 28(1):202-10. PubMed ID: 9657113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag.
    Qiu JT; Chang TC; Lin CT; Chen YM; Li FQ; Soong YK; Lai CH
    Vaccine; 2007 Jan; 25(2):253-63. PubMed ID: 16971027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
    Zhang X; Divangahi M; Ngai P; Santosuosso M; Millar J; Zganiacz A; Wang J; Bramson J; Xing Z
    Vaccine; 2007 Jan; 25(7):1342-52. PubMed ID: 17052817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.
    Mahdavi M; Ebtekar M; Khorram Khorshid HR; Azadmanesh K; Hartoonian C; Hassan ZM
    Immunol Lett; 2011 Oct; 140(1-2):14-20. PubMed ID: 21679728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.